Publications by authors named "Guldane Seval"

Claim this Profile
S
Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network.
Niels W C J van de Donk, Philippe Moreau, Jesus F San-Miguel, Maria-Victoria Mateos, Meletios A Dimopoulos, Guldane C Seval

Hemasphere· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The number of apheresis procedures to treat immune-mediated neurological diseases is on the rise.
Kaatje Le Poole, Hans Vrielink, Astrid Aandahl, Tanya Nadia Glatt, Yona Skosana, Guldane Cengiz Seval

Transfus Apher Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group.
Emel Isleyen, Nurcan Alhan, Esra Terzi Demirsoy, Ayfer Geduk, Duygu Nurdan Avci, Guldane Cengiz Seval

J Clin Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group.
Despina Fotiou, Sorina Nicoleta Badelita, Eirini Katodritou, Meral Beksac, Jelena Bila, Guldane Cengiz Seval

Clin Lymphoma Myeloma Leuk· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of PD-1 and PD-L1 expression on treatment outcomes in newly diagnosed acute myeloid leukemia patients.
Ugur Calis, Merve Aydogan, Guldane Cengiz Seval, Klara Dalva, Selami Kocak Toprak

Leuk Res Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG).
Efstathios Kastritis, Meral Beksac, Sorina Nicoleta Badelita, Eirini Katodritou, Jelena Bila, Guldane Cengiz Seval

Clin Lymphoma Myeloma Leuk· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG).
Efstathios Kastritis, Eirini Katodritou, Sorina Badelita, Jelena Bila, Güldane Cengiz Seval

Leuk Lymphoma· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Guldane Cengiz Seval

Infection· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphatidylserine and Tyro3-Axl-Mertk Receptor Tyrosine Kinase level detection in plasma and on plasma-derived extracellular vesicle surface in chronic lymphocytic leukemia.
Meltem Bay, Guldane Cengiz Seval, Oznur Coskun, Gunhan Gurman, Nesrin Ozsoy Erdas

Cell Biochem Funct· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Guldane Cengiz Seval

Infection· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová, Federico Itri, Guldane Cengiz Seval

EClinicalMedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The world apheresis association registry, 2023 update.
Hans Vrielink, Kaatje Le Poole, Bernd Stegmayr, Jan Kielstein, Gösta Berlin, Guldane Cengiz Seval

Transfus Apher Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Giuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, Francesco Marchesi, Julio Dávila-Valls, Guldane Cengiz Seval

Int J Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo expansion of natural killer cells for hematological cancer immunotherapy: a systematic review and meta-analysis.
Hikmet Can Çubukçu, Pınar Yurdakul Mesutoğlu, Güldane Cengiz Seval, Meral Beksaç

Clin Exp Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generic Lenalidomide Rivelime Versus Brand-name Revlimid® in the Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Single-center Experience on Efficacy, Safety and Survival Outcome.
Meral Beksac, Guldane Cengiz Seval, Derya Koyun, Pervin Topcuoglu, Meltem-Kurt Yuksel

Clin Lymphoma Myeloma Leuk· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Alessandro Busca, Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Guldane Cengiz Seval

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, Francesco Marchesi, Ozren Jaksic, Guldane Cengiz Seval

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia.
Zehra Narli Ozdemir, Ekin Kircali, Uğur Şahin, Guldane Cengiz Seval, Sinem Civriz Bozdağ

Clin Lymphoma Myeloma Leuk· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey.
Sylvain Lamure, Jon Salmanton-García, Elena Robin-Marieton, Ozren Jaksic, Milena Kohn, Guldane Cengiz Seval

Blood Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease.
Derya Koyun, Güldane Cengiz Seval, Ekin Kırcalı, Sinem Civriz Bozdağ, Selami Koçak Toprak

Indian J Hematol Blood Transfus· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020-Report from World Marrow Donor Association.
Monique M Jöris, Alexander H Schmidt, Stefanie N Bernas, Jay Feinberg, Nicoletta Sacchi, Guldane Cengiz Seval

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic.
Güldane Cengiz Seval, Pervin Topçuoğlu, Taner Demirer

Turk J Med Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alessandro Busca, Paolo Corradini, Guldane Cengiz Seval

J Hematol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome.
Meral Beksac, Guldane Cengiz Seval, Nicholas Kanellias, Daniel Coriu, Laura Rosiñol

Haematologica· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review.
Atilla Uslu, Güldane Cengiz Seval, Mustafa Merter, Klara Dalva, Meral Beksaç

Clin Lymphoma Myeloma Leuk· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis